Marilyn Geller
Marilyn G. Geller is Chief Executive Officer of the Celiac Disease Foundation and a globally recognized leader in celiac disease research, advocacy, and health policy. Her 2019 testimony before the U.S. House Appropriations Subcommittee helped lead to the first U.S. National Institutes of Health Notice of Special Interest for celiac disease and the first inclusion of celiac disease in the Congressionally Directed Medical Research Program. During her tenure, the Foundation convened the bipartisan U.S. Congressional Celiac Disease Caucus, launched the Celiac Disease Foundation Impact Fund, a venture philanthropy initiative with a $15 million fundraising goal, and established the Society for the Study of Celiac Disease as its Scientific Advisory Committee. She serves on the U.S. delegation to the Codex Alimentarius Committee on Food Labelling, where she works with international partners to advance the first science-based reference dose for cereals containing gluten. Marilyn created iCureCeliac®, the world’s first celiac disease patient registry, and iRecruitCeliac, the only global clinical trial recruitment network for verified celiac patients. She serves on the ISSCD Gluten Safety and Standards Committee and holds an MSPH from UCLA. At this International Celiac Disease Symposium, the Foundation is proud to present the ISSCD-SSCD Research Prizes for Excellence, recognizing outstanding contributions to celiac disease science.
Abstracts this author is presenting: